Skip to content

Alkermes

US · ALKS #1780 by market cap Listed 1970
44.94 -1.24 -2.69%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

About Alkermes

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Founded
2011
CEO
Mr. Blair C. Jackson
Employees
2,050
Headquarters
Dublin, Dublin, Ireland
Fiscal year end
12-31
Website
alkermes.com

Company profile

Exchange
US
Symbol
ALKS
Market-cap rank
#1780
Listing date
1970-01-01
Market cap
7.55B
Float cap
6.99B
Shares out
168.04M
Float shares
155.48M

Sectors & themes

Drug Manufacturers - Specialty & Generic Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:01:09 · For reference only, not investment advice and not tailored to your situation.

Alkermes discussion 0 comments

Add a comment